23 May 2013
Keywords: s-p/merck, co, pull, loratadine/montelukast, combo, nda, drug
Article | 07 July 2008
US drug majors Schering-Plough and and Merck & Co have withdrawn their New Drug Application for the loratadine/montelukast combination tablet
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
7 July 2008
22 May 2013
© 2013 thepharmaletter.com